Effects of nintedanib on circulating biomarkers of idiopathic pulmonary fibrosis

Effects of nintedanib on circulating biomarkers of idiopathic pulmonary fibrosis

Background Biomarkers that change in response to nintedanib in subjects with idiopathic pulmonary fibrosis (IPF) would be valuable. We investigated the effects of nintedanib on circulating biomarkers in subjects with IPF in the INMARK trial. Methods Subjects with IPF were randomised 1:2 to receive n...

Full description

Saved in:
Bibliographic Details
Main Authors: R. Gisli Jenkins, Vincent Cottin, Yasuhiko Nishioka, Imre Noth, Eric S. White, Carina Ittrich, Claudia Diefenbach, Klaus B. Rohr, Moisés Selman, Toby M. Maher
Format: Article
Language:English
Published: European Respiratory Society 2024-12-01
Series:ERJ Open Research
Online Access:http://openres.ersjournals.com/content/10/6/00558-2023.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items